These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3158320

  • 21. [The combined effect of an ethinylestradiol/desogestrel contraceptive combination on blood lipids and parameters of liver function and coagulation].
    Massafra C, Capitani S, Bernabei A, Scillone L.
    Rev Fr Gynecol Obstet; 1988 Apr; 83(4):251-5. PubMed ID: 2969134
    [Abstract] [Full Text] [Related]

  • 22. Desogestrel, a new progestational compound, and the liver.
    Weijers MJ.
    Arzneimittelforschung; 1983 Apr; 33(5):774-6. PubMed ID: 6223646
    [Abstract] [Full Text] [Related]

  • 23. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
    Weijers MJ.
    Clin Ther; 1982 Apr; 4(5):359-66. PubMed ID: 6461412
    [Abstract] [Full Text] [Related]

  • 24. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
    Dieben TO, van Beek A, Coelingh Bennink HJ.
    Arzneimittelforschung; 1991 Sep; 41(9):996-8. PubMed ID: 1839126
    [Abstract] [Full Text] [Related]

  • 25. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.
    Serfaty D, Vree ML.
    Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):179-89. PubMed ID: 10036600
    [Abstract] [Full Text] [Related]

  • 26. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A, Bonnar J.
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [Abstract] [Full Text] [Related]

  • 27. [Side effects of oral contraceptives in the first treatment cycle].
    Feichtinger W, Babor P, Herczeg KM, Heyda M, Hoffmann R, Plöckinger B, Steinhauser B.
    Wien Med Wochenschr; 1991 Jan; 141(18-19):412-5. PubMed ID: 1837965
    [Abstract] [Full Text] [Related]

  • 28. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D, Wildemeersch D, Verougstraete A, Creatsas G.
    Int J Fertil Menopausal Stud; 1995 Jan; 40 Suppl 2():73-9. PubMed ID: 8574253
    [Abstract] [Full Text] [Related]

  • 29. Hemostasis profile in women taking low-dose oral contraceptives.
    David JL, Gaspard UJ, Gillain D, Raskinet R, Lepot MR.
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):420-3. PubMed ID: 2142579
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of some blood clotting parameters in relation to the administration of estroprogestins].
    Orlandi F, Cattaneo C, Gabasio S, Spandre M, Paccotti P, Rustichelli S.
    Arch Sci Med (Torino); 1978 Jul; 135(4):609-17. PubMed ID: 756722
    [Abstract] [Full Text] [Related]

  • 31. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
    Briggs MH.
    J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
    [Abstract] [Full Text] [Related]

  • 32. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
    Daly L, Bonnar J.
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580
    [Abstract] [Full Text] [Related]

  • 33. Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
    Kloosterboer HJ, van Wayjen RG, van den Ende A.
    Contraception; 1986 Aug; 34(2):135-44. PubMed ID: 2946552
    [Abstract] [Full Text] [Related]

  • 34. Comparative effects of combined oral contraceptives containing desogestrel or levonorgestrel on serum lipids, lipoproteins and sex hormone binding globulin in healthy women.
    Sirimongkolkasem R, Rojanasakul A, Phiromsawat S, Chailurkit L.
    J Med Assoc Thai; 1988 Jul; 71 Suppl 2():68-73. PubMed ID: 2972791
    [Abstract] [Full Text] [Related]

  • 35. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
    Weijers MJ.
    Fortschr Med; 1982 Apr 29; 100(16):764-7. PubMed ID: 6211403
    [Abstract] [Full Text] [Related]

  • 36. Clinical experience with an ethinyl estradiol-desogestrel oral contraceptive.
    Van Trappen Y, Duvivier P, Thiery M, Van Kets H, Defoort P, Parewijck W, Derom R, Kermans G, Schoofs P.
    Arzneimittelforschung; 1989 Jun 29; 39(6):717-9. PubMed ID: 2528355
    [Abstract] [Full Text] [Related]

  • 37. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB.
    J Reprod Med; 1983 Jan 29; 28(1 Suppl):81-4. PubMed ID: 6403705
    [Abstract] [Full Text] [Related]

  • 38. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
    Oelkers W, Helmerhorst FM, Wuttke W, Heithecker R.
    Gynecol Endocrinol; 2000 Jun 29; 14(3):204-13. PubMed ID: 10923282
    [Abstract] [Full Text] [Related]

  • 39. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
    Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Lange E, Mellinger U, Kuhl H.
    Contraception; 2008 Nov 29; 78(5):384-91. PubMed ID: 18929735
    [Abstract] [Full Text] [Related]

  • 40. The clinical and biochemical effects of two combination oral contraceptive agents.
    Sapire KE, Berger GM, Maritz JS.
    S Afr Med J; 1991 Apr 06; 79(7):376-9. PubMed ID: 1826569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.